Therefore, the immune excluded type and the ignored immunophenotypes in TNBC and metastatic TNBC validated by the gene classifier accurately do not respond to anti-PD1 treatment, which can be considered as a variant of cold tumor [72]. This evidence concerns the gene PDCD1 and neoplasm.